Search Results
(±)12-HEPE Please inquire | Purity Not Available
BOC Sciences
(±)12-HEPE 250 µg | ≥98%
Cayman Chemical
A non-enzymatic oxidation product of EPA that inhibits platelet aggregation
More Information Supplier Page(±)12-HEPE
(±)12-HEPE 100 µg | ≥98%
Cayman Chemical
A non-enzymatic oxidation product of EPA that inhibits platelet aggregation
More Information Supplier Page(±)12-HEPE
(±)12-HEPE 50 µg | ≥98%
Cayman Chemical
A non-enzymatic oxidation product of EPA that inhibits platelet aggregation
More Information Supplier Page(±)12-HEPE
(±)12-HEPE 25 µg | ≥98%
Cayman Chemical
A non-enzymatic oxidation product of EPA that inhibits platelet aggregation
More Information Supplier Page(±)12-HEPE
(±)12-HEPE 10mg | ≥98%
Musechem
(±)12-HEPE 1 mg | Purity Not Available
TargetMol
(±)12-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 12(S)-HEPE and 12(R)-HEPE. The biological activity of (±)12-HEPE is likely mediated by one of the individual isomers, most commonly the 12(S) isomer in mammalian systems. 12-HEPE inhibits platelet aggregation with the same potency as 12-HETE, exhibiting IC50 values of 24 and 25 […]
More Information Supplier Page(±)12-HEPE
(±)12-Hete inquiry | 95%
Alfa Chemistry
(±)12-HETE 250 µg | ≥95%
Cayman Chemical
(±)12-HETE
(±)12-HETE 100 µg | ≥95%
Cayman Chemical
(±)12-HETE
